参考文献/References:
[1] Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
[2] Thomas A,Ashcraft A.Type 2 diabetes risk among Asian Indians in the US: A pilot study[J].Nurs Res Pract,2013,2013:492893.
[3] Weijers RN,Bekedam DJ,Oosting H.The prevalence of type 2 diabetes and gestational diabetes mellitus in an inner city multi-ethnic population[J].Eur J Epidemiol,1998,14(7):693-699.
[4] McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans[J].Diabetes Care,2004,27(1):66-69.
[5] Creatore MI,Moineddin R,Booth G,et al.Age-and sex-related prevalence of diabetes mellitus among immigrants to Ontario, Canada[J].Canad Med Assoc J,2010,182(8):781-789.
[6] Zheng Y,Lamoureux EL,Ikram MK,et al.Impact of migration and acculturation on prevalence of Type 2 diabetes and related eye complications in Indians living in a newly urbanised society[J].PLoS One, 2012,7(4):e34829.
[7] Wu Y,Wu T,Wu J,et al.Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet[J].J Endocrinol,2013,219(3):195-204.
[8] Misra R,Patel TG,Davies D,et al.Health promotion behaviors of Gujurati Asian Indian immigrants in the United States[J].J Immigr Health,2000,2(4):223-230.
[9] Misra KB,Endemann SW,Ayer M.Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in northern California[J].Ethnic Dis,2005,15(4):627-634.
[10] O'Loughlin J,Maximova K,Tan Y,et al.Lifestyle risk factors for chronic disease across family origin among adults in multiethnic, low-income, urban neighborhoods[J].Ethnic Dis,2007,17(4):657-663.
[11] Malenfant C.A comparative study of South Indian children with Tamil children born in France. National Center for Scientific Research,(CNRS), Nutrition, Paris, France[J].Indian J Med Res,2009,130(5):590-592.
[12] Bhardwaj S, Misra A, Khurana L, et al.Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation[J].Asia Pac J Clin Nutr,2008,17(Suppl 1):172-175.
[13] Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics——2014 update: a report from the American Heart Association[J].Circulation,2014,129(3):e28-e292.
[14] Kandula NR,Diez-Roux AV,Chan C,et al.Association of acculturation levels and prevalence of diabetes in the multi-ethnic study of atherosclerosis(MESA)[J].Diabetes Care,2008,31(8):1621-1628.
[15] Valerio L,Milozzi J,Figueredo A,et al.Prevalence of diabetes mellitus in young Asian Indian immigrants in Santa Coloma de Gramenet(Spain)[J].Med Clin(Barc), 2006,126(2):53-56.
[16] Johansson S,Iliadou A,Bergvall N,et al.The association between low birth weight and type 2 diabetes: contribution of genetic factors[J].Epidemiology,2008,19(5):659-665.
[17] Cekmez F,Canpolat F,Pirgon O,et al.Adiponectin and visfatin levels in extremely low birth weight infants; they are also at risk for insulin resistance[J].Eur Rev Med Pharmacol Sci, 2013,17(4):501-506.
[18] Forsén T,Eriksson J,Tuomilehto J,et al.The fetal and childhood growth of persons who develop type 2 diabetes[J].Ann Intern Med,2000,133(3):176-182.
[19] Gupta M, Gupta R, Pareek A, et al. Low birth weight and insulin resistance in mid and late childhood[J].Indian Pediatr,2007,44(3):177-184.
[20] von Bonsdorff MB, Muller M, Aspelund T, et al. Persistence of the effect of birth size on dysglycaemia and type 2 diabetes in old age: AGES-Reykjavik Study[J].Age(Dordrecht,Netherlands), 2013,35(4):1401-1409.
[21] Urquia ML, Glazier RH, Blondel B, et al. International migration and adverse birth outcomes: role of ethnicity, region of origin and destination[J].J Epidemiol Commun Health,2010,64(3):243-251.
[22] Dasgupta K, Khan S, Ross NA. Type 2 diabetes in Canada: concentration of risk among most disadvantaged men but inverse social gradient across groups in women[J].Diabet Med,2010,27(5):522-531.
[23] Espelt A, Borrell C, Palència L, et al. Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe[J].Gac Sanit, 2013,27(6):494-501.
[24] Abouzeid M, Philpot B, Janus ED, et al.Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia[J].BMC Public Health,2013,13:252.
[25] Hasson RE, Adam TC, Pearson J, et al. Sociocultural and socioeconomic influences on type 2 diabetes risk in overweight/obese African-American and Latino-American children and adolescents[J].J Obes, 2013,2013:512914.
[26] Vandenheede H, Deboosere P, Stirbu I, et al. Migrant mortality from diabetes mellitus across Europe:the importance of socio-economic change[J].Eur J Epidemiol,2012,27(2):109-117.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(05):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[7]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[8]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[9]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
[10]陈金安 柳岚 蒋克春 王爱萍.糖尿病足溃疡中趋化因子的作用及机制[J].国际内分泌代谢杂志,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]
Chen Jinan,Liu Lan,Jiang Kechun,et al.Roles of chemokines in diabetic foot ulcer and the mechanisms[J].International Journal of Endocrinology and Metabolism,2015,(05):357.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.018]